Industry Developments

BMI View: While allegations that Brazil's ongoing outbreak of Chagas disease stems from failings at its regulator is embarrassing for state health officials, we believe increasing... 2011-10-17

Since BMI launched its Global Company Strategy reports in July 2011, stock markets worldwide have experienced a period of extreme uncertainty and share price weakness in light of the... 2011-10-17

BMI View: BMI's Pharmaceuticals and Healthcare Business Environment Ratings (BERs), which assess markets according to their risk/reward profile, show that the Americas have improved... 2011-10-14

BMI View: Where previous governments were unable to negotiate trade favourable terms, President Juan Manuel Santos has succeeded at ratifying Colombia's free trade agreement (FTA) with... 2011-10-13

BMI View: With Latin America's economic outlook looking increasingly positive and consumer demand for pharmaceutical goods becoming more discerning, we believe key markets across the... 2011-10-12

BMI View: Despite Moksha8's impressive track record in commercialising third-party branded medicines in Brazil and Mexico, we believe the company's future success could be severely... 2011-10-11

BMI View: Despite President Ollanta Humala's government demonstrating a strong will to combat Peru's mounting healthcare problems, we maintain the view that the government's inability... 2011-10-10

BMI View: Switzerland-based Actavis has deflected disappointing news in Poland by announcing an aggressive growth strategy in Latin America. Despite being a late entrant into the region's... 2011-10-07

BMI View: Virtually unknown to foreign investors 20 years ago, Colombia's willingness to adopt international patent standards and liberal trade relations have made multinational drugmakers... 2011-10-06

BMI View: Brazil's state regulator's decision to approve the sale and marketing of a widely banned weight loss supplement, even under strict conditions, raises concerns over patient... 2011-10-05